# Sugammadex To IMprove Bowel Function

> **NCT04546672** · PHASE4 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 120 (actual)

## Conditions studied

- Bowel Dysfunction
- Postoperative Complications
- Neuromuscular Blockade

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Neostigmine

## Key facts

- **NCT ID:** NCT04546672
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-16
- **Primary completion:** 2023-06-14
- **Final completion:** 2023-08-13
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04546672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04546672, "Sugammadex To IMprove Bowel Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04546672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*